Summary
Myogen Sustagen 250, an injectable testosterone blend, was independently analyzed to verify its composition and quality. This product, manufactured under batch number EM-18007, with a manufacturing date of 24 February 2018 and an expiration date of 31 January 2021, was submitted by AnabolicLab.com for testing at SIMEC AG, a reputable pharmaceutical laboratory.
The results confirmed the presence of the labeled testosterone esters—Testosterone Phenylpropionate, Testosterone Isocaproate, Testosterone Decanoate, and Testosterone Propionate—at slightly higher concentrations than specified on the label, indicating good manufacturing consistency. However, microbiological testing detected contamination, which raises safety concerns. This contamination underscores the need for rigorous quality control by manufacturers to ensure product safety and consumer protection.
Detailed Report
Product Overview
- Manufacturer: Myogen
- Product Name: Sustagen 250
- Batch Number: EM-18007
- Manufacture Date: 24 February 2018
- Expiration Date: 31 January 2021
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: C 81010
- Testing Ordered: 25 February 2019
- Sample Received: 25 February 2019
- Analysis Conducted By: SIMEC AG
- Product Submitted By: AnabolicLab.com
- Analysis Paid For By: AnabolicLab.com
Testing Results
| Testosterone Ester | Specification (Label Claim) | Measured Concentration | Accuracy |
|---|---|---|---|
| Testosterone Phenylpropionate | 60 mg/ml | 62 mg/ml | 103.3% |
| Testosterone Isocaproate | 60 mg/ml | 65 mg/ml | 108.3% |
| Testosterone Decanoate | 100 mg/ml | 104 mg/ml | 104.0% |
| Testosterone Propionate | 30 mg/ml | 31 mg/ml | 103.3% |
| Microbiological Testing | Result | Specification |
|---|---|---|
| TAMC | Detectable/ml | Does Not Comply |
| TYMC | Not Detectable/ml | Complies |
- Test Report Number: C 81010
Evaluation of Independent Testing
The independent analysis of Myogen Sustagen 250 revealed a mixed outcome. While the product contained the labeled testosterone esters at slightly higher concentrations than claimed, indicating reliable manufacturing practices, the detection of microbiological contamination is a significant safety concern. Contamination poses potential health risks, especially for injectable products, which are expected to meet stringent sterility requirements.
These findings emphasize the importance of manufacturers implementing rigorous quality control measures to ensure both composition accuracy and microbiological safety. Independent testing remains a critical tool for identifying discrepancies and promoting consumer safety.
Conclusion
While Myogen Sustagen 250 demonstrated accurate composition regarding its labeled testosterone esters, the detection of microbiological contamination highlights a serious safety issue. This finding underscores the need for enhanced manufacturing and quality control processes to protect consumers. Independent testing is vital for promoting transparency, ensuring product integrity, and safeguarding public health.
Disclaimer
This report is published for educational and harm reduction purposes. Independent testing provides valuable insights; however, these findings pertain solely to the analyzed batch and may not represent the entire product line. Consumers are encouraged to critically assess this information alongside additional independent analyses to make informed decisions.
Discuss the MyoGen Sustagen 250 lab test results on the AnabolicLab Forum.
(The following images are photographs of the actual product that was submitted for testing.)
